Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Waxman/Hatch Debate Moves Forward: Generic Biologics Not Ruled Out

Executive Summary

A generic approval process for biological product is being recognized as one item for consideration in reform of the Waxman/Hatch Act by the law's key sponsor in the Senate.

You may also be interested in...



Alliance for Aging Research Waxman/Hatch Position Mirrors BIO Stance

The Alliance for Aging Research's support of patent restoration for clinical development time echoes BIO's position on Waxman/Hatch Act reform.

Alliance for Aging Research Waxman/Hatch Position Mirrors BIO Stance

The Alliance for Aging Research's support of patent restoration for clinical development time echoes BIO's position on Waxman/Hatch Act reform.

Product Life Cycle Limits May Level Playing Field For Generics - TCI's DiCicco

Legislation that would limit branded product life cycle management strategies could level the playing field for generic drug products, Technology Catalysts International President Richard DiCicco said at the International Generic Drug Forum Jan. 24 in Washington, D.C.

UsernamePublicRestriction

Register

PS035349

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel